Viewing Study NCT00058812

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2026-04-24 @ 6:47 AM
Study NCT ID: NCT00058812
Status: COMPLETED
Last Update Posted: 2015-01-29
First Post: 2003-04-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts
Sponsor: Baylor College of Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epstein-Barr Virus Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cytotoxic T Lymphocytes View
None bone marrow transplant View
None EBV+ lymphoproliferative disease View